Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-06-24

Clinical Trial Update: A Trial to Assess the Efficacy and Safety of M1 Pram P037 Prandial Insulin in Subjects With Type 1 Diabetes (T1DM) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the efficacy and safety of M1 Pram P037 Prandial Insulin in adults with Type 1 Diabetes Mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • M1 Pram P037 Prandial Insulin

Snippet

Sponsor: Adocia | Conditions: Type 1 Diabetes Mellitus | Phase 2 | Status: COMPLETED